Published in

Oxford University Press (OUP), Annals of Oncology, (29), p. viii331, 2018

DOI: 10.1093/annonc/mdy283.140

Links

Tools

Export citation

Search in Google Scholar

PRISM: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO